Pulmonary Vascular Complications of Liver Disease 3

Brief description of study

The main purpose of this study is to determine if certain genes, hormones, or other factors predict the risk of developing lung vessel disease in patients with liver disease and whether they determine outcome. Patients in need of a liver transplant evaluation or have portopulmonary hypertension or are suspected of having portopulmonary hypertension will be recruited to participate in a Study Day Visit where blood/urine will be collected and diagnostic tests will be performed. Most of these tests are considered standard of care.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    liver, Pulmonary Vascular
  • Age: Between 18 Years - 99 Years
  • Gender: All
Updated on 09 Mar 2024. Study ID: 831382
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center